Cellmid Limited operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Cellmid Limited with three other
companies in this sector in Australia:
Factor Therapeutics Ltd
sales of 4.02 million Australian Dollars [US$3.18 million]
of which 100%
(4.22 million Australian Dollars [US$3.34 million]
of which 98%
was Cancer Immunotherapy), and
Medlab Clinical Ltd
(4.45 million Australian Dollars [US$3.52 million]
Cellmid Limited reported sales of A$4.72 million (US$3.74 million)
June of 2017.
increase of 39.4%
versus 2016, when the company's sales were A$3.39 million.